RAG Deficiency: Two Genes, Many Diseases
- 25 July 2018
- journal article
- review article
- Published by Springer Nature in Journal of Clinical Immunology
- Vol. 38 (6) , 646-655
Abstract
Purpose To review the clinical and laboratory spectrum of RAG gene defects in humans, and discuss the mechanisms underlying phenotypic heterogeneity, the basis of immune dysregulation, and the current and perspective treatment modalities. Methods Literature review and analysis of medical records Results RAG gene defects in humans are associated with a surprisingly broad spectrum of clinical and immunological phenotypes. Correlation between in vitro recombination activity of the mutant RAG proteins and the clinical phenotype has been observed. Altered T and B cell development in this disease is associated with defects of immune tolerance. Hematopoietic cell transplantation is the treatment of choice for the most severe forms of the disease, but a high rate of graft failure has been observed. Conclusions Phenotypic heterogeneity of RAG gene defects in humans may represent a diagnostic challenge. There is a need to improve treatment for severe, early-onset forms of the disease. Optimal treatment modalities for patients with delayed-onset disease presenting with autoimmunity and/or inflammation remain to be defined.Keywords
This publication has 92 references indexed in Scilit:
- Unrelated Hematopoietic Cell Transplantation in a Patient with Combined Immunodeficiency with Granulomatous Disease and Autoimmunity Secondary to RAG DeficiencyJournal of Clinical Immunology, 2016
- Late Onset Hypomorphic RAG2 Deficiency Presentation with Fatal Vaccine-Strain VZV InfectionJournal of Clinical Immunology, 2015
- RAG1 Deficiency May Present Clinically as Selective IgA DeficiencyJournal of Clinical Immunology, 2015
- Identification of Patients with RAG Mutations Previously Diagnosed with Common Variable Immunodeficiency DisordersJournal of Clinical Immunology, 2014
- The RAG Recombinase Dictates Functional Heterogeneity and Cellular Fitness in Natural Killer CellsCell, 2014
- Newborn Screening for Severe Combined Immunodeficiency in 11 Screening Programs in the United StatesJAMA, 2014
- Atypical Severe Combined Immunodeficiency Caused by a Novel Homozygous Mutation In Rag1 Gene in a Girl who Presented with Pyoderma Gangrenosum: A Case Report and Literature ReviewJournal of Clinical Immunology, 2014
- RAG1 Reversion Mosaicism in a Patient with Omenn SyndromeJournal of Clinical Immunology, 2014
- Exome Sequencing Reveals RAG1 Mutations in a Child with Autoimmunity and Sterile Chronic Multifocal Osteomyelitis Evolving into Disseminated Granulomatous DiseaseJournal of Clinical Immunology, 2013
- RAG-dependent primary immunodeficienciesHuman Mutation, 2006